We are live on ! Find out more
GEA

Glen Eagle Advisors Portfolio holdings

AUM $714M
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+18.87%
3 Year Est. Return
+62.99%
5 Year Est. Return
+76.32%
10 Year Est. Return
AUM
$322M
AUM Growth
+$35.3M
Cap. Flow
+$17M
Cap. Flow %
5.28%
Top 10 Hldgs %
30.83%
Holding
1,070
New
67
Increased
247
Reduced
122
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 12.22%
2 Healthcare 10.01%
3 Financials 6.51%
4 Consumer Discretionary 4.83%
5 Communication Services 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGRW icon
126
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.5B
$518K 0.16%
8,680
+1,008
+13% +$59.5K
WY icon
127
Weyerhaeuser
WY
$17B
$513K 0.16%
14,916
+5,207
+54% +$193K
BAB icon
128
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$509K 0.16%
15,333
+870
+6% +$28.4K
LAND
129
Gladstone Land Corp
LAND
$368M
$502K 0.16%
20,881
+7,984
+62% +$181K
IHI icon
130
iShares US Medical Devices ETF
IHI
$2.95B
$494K 0.15%
8,208
SLV icon
131
iShares Silver Trust
SLV
$27.8B
$466K 0.14%
19,248
-234
-1% -$5.79K
BSCO
132
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$465K 0.14%
20,944
+4,310
+26% +$95.8K
SO icon
133
Southern Company
SO
$108B
$458K 0.14%
7,566
-200
-3% -$12.8K
DOW icon
134
Dow Inc
DOW
$22.3B
$451K 0.14%
7,125
-239
-3% -$15.8K
BSCM
135
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
$444K 0.14%
20,558
+2,618
+15% +$56.6K
C icon
136
Citigroup
C
$220B
$439K 0.14%
6,203
+1,791
+41% +$133K
XLV icon
137
State Street Health Care Select Sector SPDR ETF
XLV
$41.6B
$439K 0.14%
3,484
IJH icon
138
iShares Core S&P Mid-Cap ETF
IJH
$122B
$431K 0.13%
8,025
+655
+9% +$35.4K
BOND icon
139
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.26B
$426K 0.13%
3,838
+32
+0.8% +$3.53K
HON icon
140
Honeywell
HON
$77.3B
$418K 0.13%
2,020
+254
+14% +$53.7K
FCOR icon
141
Fidelity Corporate Bond ETF
FCOR
$352M
$417K 0.13%
7,491
-788
-10% -$43.3K
NDAQ icon
142
Nasdaq
NDAQ
$52B
$415K 0.13%
7,074
+51
+0.7% +$2.81K
BX icon
143
Blackstone
BX
$150B
$412K 0.13%
4,245
BF.B icon
144
Brown-Forman Class B
BF.B
$11.7B
$412K 0.13%
5,500
GLD icon
145
SPDR Gold Trust
GLD
$130B
$397K 0.12%
2,398
-274
-10% -$46.6K
VO icon
146
Vanguard Mid-Cap ETF
VO
$105B
$396K 0.12%
6,668
+172
+3% +$9.97K
BAC icon
147
Bank of America
BAC
$429B
$393K 0.12%
9,543
-622
-6% -$25.5K
LMT icon
148
Lockheed Martin
LMT
$129B
$389K 0.12%
1,028
+20
+2% +$7.69K
BSCL
149
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
$385K 0.12%
18,233
-819
-4% -$17.3K
ABT icon
150
Abbott
ABT
$175B
$382K 0.12%
3,293

Similar funds

Glen Eagle Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Glen Eagle Advisors held 1,070 positions worth $322M, up 12% from $286M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Glen Eagle Advisors deployed $17M of net new capital in Q2 2021, opening 67 new positions and adding to 247 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 10,640 shares worth $287K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares AAA-A Rated Corporate Bond ETF, an estimated $3.37M trimmed.

  • Glen Eagle Advisors's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 10,640 shares worth $287K.
  • Glen Eagle Advisors added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $2.53M increase.
  • Glen Eagle Advisors's biggest Q2 2021 reduction was iShares AAA-A Rated Corporate Bond ETF, cutting an estimated $3.37M.
  • Glen Eagle Advisors fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $26.9K.
  • Glen Eagle Advisors's ten largest holdings make up 31% of its $322M portfolio in Q2 2021.
  • Glen Eagle Advisors opened 67 new positions and closed 30 in Q2 2021.
  • Glen Eagle Advisors's portfolio value rose 12% quarter-over-quarter to $322M.

Based on Glen Eagle Advisors's 13F filing for Q2 2021, filed 13 Aug 2024.